Press and Media

Thank you for your interest in covering the AANEM Annual Meeting. Please join us at the 2026 AANEM Annual Meeting from Sept.29 to Oct. 2 in Orlando, Florida. Journalists covering the annual meeting and posting stories on social media channels are encouraged to use the official meeting hashtag #AANEMinOrlando.
Welcome to the AANEM Annual Meeting Media & Access Guidelines.

To support accurate coverage of neuromuscular and electrodiagnostic medicine, protect the integrity of scientific research, and respect the privacy of presenters, AANEM maintains clear standards for media credentialing, venue access, embargoes, and commercial activity at the meeting. Whether you are a professional journalist, an industry partner, or a scientific attendee, please review the policies below to understand access options, reporting guidelines, and expectations while onsite.

 

Media registration Aug. 1 – Oct. 2, 2026
Media may request specific interviews Sept. 1 – Oct. 2, 2026
Media may request photo/video access to specific speakers, sessions, and/or workshops Sept. 1 – Sept. 29, 2026
2026 AANEM Annual Meeting Sept. 29 – Oct. 2, 2026

 

 

1. Press credentialing

Media credentialing standards
AANEM issues media passes to professional journalists whose primary role is news reporting rather than general influence or promotional activity. To obtain complimentary press registration, applicants must provide documentation demonstrating their status as professional journalists, such as:

  • Print/online journalists: A recognized press card, an assignment letter from an editor on official letterhead, and recent bylined articles (past 6 months) related to medical or scientific topics.
  • Broadcast media: Official press credentials issued by a government or media organization, along with a formal letter from a producer.
  • Freelancers: Evidence of an active portfolio with relevant scientific articles/news coverage within the last year.

Media may submit credentials and/or proof of professional status by emailing them to media@aanem.org.

Communications, PR, and marketing professionals from commercial companies, pharmaceutical firms, or medical device corporations are not eligible for complimentary media registration and should register as Industry Partners or Exhibitor Representatives.

 

2. Access and restricted zones

A media pass provides access to designated areas and activities within the meeting; it does not provide unrestricted access to all rooms and events ..

  • Press Room / Media Center: A dedicated workspace reserved for badged media members, with workspace, high‑speed Wi‑Fi, and interview areas where journalists can meet with presenters or association leadership.
  • Scientific sessions: Media may attend open scientific sessions and oral abstract presentations to listen and take notes; video and/or audio recording requires prior written approval.
  • Poster Sessions: Photography or video recording of poster presentations is generally not permitted unless explicit written permission is granted by the presenting author to help protect unpublished data and intellectual property.
  • Workshops: Photography or video recording of workshops is generally not permitted unless explicit written permission is granted by AANEM

 

3. Interview requests

  • Media may request interviews with specific presenters, speakers, or AANEM members. Requests should be submitted in writing to media@aanem.org and include the name of the intended interviewee, along with brief context on how the interview will be used in the news story. If you do not have a specific individual in mind but know the type of expert you need, please describe this in detail in your request.
  • Submitting a request does not guarantee interview availability, and participation is at the discretion of the attendee and AANEM.


4. Photo and video access

Media may request access to specific presentations or sessions to capture photos and/or video. Requests should be submitted in writing to media@aanem.org and include the session name, the type of media you are seeking (for example, photos only or short video clips), and how it will be incorporated into your reporting.

AANEM’s priority is to support scientific communication while protecting attendees’ intellectual property, so photo or video requests may be approved, modified, or declined based on these considerations.

 

5. AANEM suitcasing policy

Definition

“Suitcasing” refers to companies or individuals who are not official exhibitors or sponsors using the AANEM Annual Meeting for commercial purposes such as marketing, promotion, or business solicitation. This includes activities like distributing promotional materials, conducting sales conversations, or marketing products and services in public spaces such as aisles, session rooms, hallways, meeting areas, exhibit and poster halls, or hotel facilities associated with the meeting. It also includes soliciting business within another company’s exhibit space or using the meeting to gain commercial or competitive advantage without being an approved exhibitor or sponsor.

Prohibited attendance and activities

To support a scientific, educational focus and honor commitments made to exhibitors and sponsors, AANEM generally does not allow the following individuals to attend the meeting in any capacity (including as regular scientific attendees):

  • Pharmaceutical or device company competitor investigators whose primary purpose is competitive intelligence gathering.
  • Third‑party or in‑house competitive intelligence professionals attending on behalf of pharmaceutical, biotechnology, device, or related healthcare companies.
  • Pharmaceutical, biotechnology, device, or healthcare marketing strategists, branding, or commercialization personnel whose primary purpose is to observe, analyze, or leverage the meeting for marketing, product positioning, or competitive assessment.

If an individual’s primary objective in attending the AANEM Annual Meeting is to collect competitive intelligence, assess competitors, monitor product positioning, or otherwise gather information for commercial advantage rather than for clinical, scientific, or educational purposes, their attendance is not permitted under this policy in any registration category.

Individuals who are not official exhibitors or sponsors and who are observed engaging in promotional, marketing, or solicitation activities, or acting in a competitive‑intelligence or marketing capacity, may:

  • Be declined registration or badge pickup.
  • Be asked to leave the meeting and related venues.
  • Be restricted from attending future AANEM events.

Enforcement decisions are made at AANEM’s discretion to protect the meeting environment and its participants.

 

6. Embargo policies

To help coordinate fair and accurate news coverage, AANEM may share press releases and abstract details with registered journalists in advance under embargo. Embargoed information may not be published until the specified date and time.

  • Standard abstracts: Embargoes are lifted when the abstract is published online or when the annual meeting begins.
  • Violations: Material breaches of embargo terms may result in revocation of media credentials for current and future meetings and removal from AANEM’s press list


7. Digital and social media

AANEM’s guidelines distinguish between professional journalism and scientific communication by attending physicians, researchers, advanced practice providers, technicians, and other allied health care providers who share insights online.

  • “Attendee Scientific Communication: AANEM encourages attending physicians, researchers, and other allied health care professionals to use official meeting hashtags to live‑tweet or share high‑level insights, which is viewed as public scientific communication rather than professional journalism.
  • Slides/data capture: Registered attendees are not permitted to take direct photos of presentation slides, proprietary graphics, or raw clinical data tables unless the presenter clearly indicates “Open Access / Sharing Welcome” on their slides or the poster presenter approves it.

 

8. On-site and on-call media contacts:

Ian Roth – Marketing and Communications Manager, AANEM – 507-258-6575

Kati Poterucha – Marketing and Communications Director, AANEM – 507-258-6571


Please review the Abstract Embargo Policy. For questions regarding AANEM Annual Meeting policies, please email media@aanem.org.

View the latest AANEM Achievement Award winners, the American Neuromuscular Foundation (ANF) Abstract Award winners, and the latest AANEM news articles on News Express.

Questions? Check out the frequently asked questions below or contact media@aanem.org

Frequently Asked Questions

Q: When will be content of abstracts be viewable, as opposed to just the titles?
A: The abstract content will be available at the annual meeting during the Poster Hall hours. We do not provide abstract presenter information or slides ahead of time. All available information can be found in the AANEM Abstract Guide online when it becomes available.

Q: How do I reach out to abstract or session presenters for an interview?
A:
 We do not offer member contact information. To connect with abstract or session presenters, review the AANEM Annual Meeting Program when available. Find the topics of interest and connect with the presenter after their lecture or during their abstract poster session time. Currently there is no interview option for virtual attendees.

Q: When can I share information?
A: The embargo on the abstracts themselves is lifted when they have been published in Muscle & Nerve and online in the AANEM Abstract Guide. However, the additional information beyond what is in the abstract itself is still embargoed. 

AANEM requires information that goes beyond that which is contained within the abstract, e.g., the release of data not included in the abstract, discussion of the abstract done as part of a scientific presentation, etc. to be embargoed until the start of the annual meeting. Please see the Abstract Embargo Policy.

Q: Will the Abstract Award Reception feature the best posters? 
A: The Abstract Award Reception is a social hour in honor of the abstract award winners where all authors, including award winners, will be available to discuss research. 

Q: Original research is ONLY presented as posters, correct?
A: Yes - the research is presented in the Poster Hall via abstract posters.

Science News: Provocative Test Timing Does Not Predict Carpal Tunnel Severity

Sep 16, 2026, 07:00 by Lily Duquaine (Admin)
This cross-sectional correlational study examined whether the duration required to provoke symptoms during a controlled-pressure provocative test is associated with electrodiagnostic severity in patients with carpal tunnel syndrome (CTS).

Submitted by: Rebecca O’Bryan, MD

Citation: Iamchaimongkol A, Leeareekun K, Chira-Adisai W, Keesukphan A. Correlation between controlled-pressure provocative test duration and electrodiagnostic severity in carpal tunnel syndrome. J Rehabil Med. 2026 Jan 27;58:jrm44203. doi: 10.2340/jrm.v58.44203. PMID: 41601199; PMCID: PMC12856761

Summary:

This cross-sectional correlational study examined whether the duration required to provoke symptoms during a controlled-pressure provocative test is associated with electrodiagnostic severity in patients with carpal tunnel syndrome (CTS). The study was conducted at Ramathibodi Hospital, Mahidol University, Thailand, between September 2023 and July 2024. Eligible participants were adults aged 18 years or older with clinical symptoms of CTS and electrodiagnostic confirmation, classified as mild, moderate, or severe according to the 2011 American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) criteria. Exclusion criteria included non-idiopathic median nerve pathology (e.g., infection, tumor, or trauma), peripheral neuropathy, prior carpal tunnel release surgery, cervical radiculopathy, or brachial plexopathy.

Following electrodiagnostic evaluation, participants underwent a controlled-pressure provocative test based on the Durkan carpal compression test. This standardized technique employed a sphygmomanometer cuff placed around the wrist, inflated with additional manual pressure to achieve a target pressure of 150 mmHg. The time from pressure application to symptom onset was recorded, with a maximum test duration of 30 seconds.

A total of 160 hands were initially enrolled; 8 were excluded based on predefined criteria. Of the remaining 152 hands, 28 yielded negative provocative test results. The final analysis included 124 hands from 78 patients. Statistical analysis demonstrated no significant correlation between the duration of symptom provocation during the controlled-pressure test and electrodiagnostic severity of CTS. Although patients with mild CTS tended to exhibit longer median times to symptom onset compared with those with severe CTS, these differences were not statistically significant. The overall median time to symptom onset across all severity groups was 15 seconds.

The authors conclude that while controlled-pressure provocative testing remains useful for the diagnosis of CTS, the duration of symptom provocation does not reliably reflect disease severity. Consequently, test timing should not be used as a surrogate for electrodiagnostic severity. Electrodiagnostic studies remain essential for accurate severity grading and for guiding treatment decisions. These findings reinforce that provocative tests should be interpreted qualitatively (positive versus negative), rather than quantitatively, when assessing CTS severity.

Comments:

This study is in line with previous studies indicating that clinical presentation and provocative maneuvers do not correlate with electrodiagnostic severity. Electrodiagnostic study should be employed to determine severity prior to surgical planning.

Why is this article interesting/relevant to the AANEM audience?

This article is particularly relevant as it reinforces the importance of our role in the diagnosis of carpal tunnel syndrome and in the determination of its severity.